Outcomes of Quantitative Flow Ratio-Based Percutaneous Coronary Intervention in an All-Comers Study.

Rui Zhang,K. Dou,C. Guan,Tongqiang Zou,Min Zhang,S. Yuan,Z. Qiao,Lihua Xie,Zhongwei Sun,L. Song,S. Qiao,G. Stone,Bo Xu
DOI: https://doi.org/10.4244/EIJ-D-21-00176
2021-07-06
EuroIntervention
Abstract:BACKGROUND Quantitative flow ratio (QFR) is a novel angiography-based physiological index for fast computation of fractional flow reserve without use of pressure wire or induction of hyperemia. AIMS We sought to investigate the prevalence and prognostic implications of achieving physiology-consistent percutaneous coronary intervention (PCI) according to the baseline angiographic QFR in an all-comers cohort. METHODS QFR was retrospectively analyzed from the angiograms of 1,391 patients enrolled in the randomized PANDA III trial. Patients in whom all functionally ischemic vessels (baseline QFR ≤0.80) were treated and in whom all non-ischemic vessels (baseline QFR >0.80) were deferred were termed to have had QFR-consistent treatment; otherwise they were termed to have QFR-inconsistent treatment. The major outcome was 2-year major adverse cardiac events (MACE, composite of all-cause death, all MI, or any ischemia-driven revascularization). RESULTS Overall, 814 (58.5%) patients had QFR-consistent PCI, while 577 (41.5%) patients received QFR-inconsistent PCI. Patients with QFR-consistent vs. those with QFR-inconsistent treatment had a lower risk of 2-year MACE (8.4% vs. 14.7%; hazard ratio [HR] 0.56 [95%CI, 0.41-0.78]). After adjusting for differences in baseline covariates, 2-year rates of MACE remained significantly lower in the QFR-consistent group (8.8% vs. 13.6%; adjusted HR 0.64 [95% CI, 0.44-0.93]), mainly due to reduced ischemia-driven revascularization (2.9% vs. 8.0%; adjusted HR 0.35 [95% CI, 0.20-0.60]). CONCLUSIONS In this post hoc analysis of an all-comers PCI trial, approximately 60% of patients were treated in accordance with what QFR measurement would have recommended, the achievement of which was associated with improved 2-year clinical outcomes.
Medicine
What problem does this paper attempt to address?